Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor Symptoms
1 other identifier
observational
107
1 country
1
Brief Summary
Background: Approximately 40% of patients with Parkinson's disease (PD) have cognitive impairments. There is a lack of consensus as to the extent to which psychiatric symptoms, depression, age at disease onset, disease duration, and medication is related to the type and severity of cognitive impairment. This discrepancy can in part be caused by the lack of distinction between patients with different motor symptoms and disease severity. Objective: To identify the extent to which psychiatric symptoms, depression, age at disease onset, disease duration, and medication is related to the severity and type of cognitive dysfunction in patients with idiopathic PD categorized according to motor symptoms and disease severity. Methods: the population of patients with PD in the old county of Aarhus is described on the background of medical records, and stratified in accordance to age, sex and cardinal symptoms. Through proportional allocation a sample of a minimum of 50 patients with PD is drawn from the population. The patients and 30 healthy matched controls will undergo comprehensive neuropsychological assessment including tests of language, memory, executive function, and visuospatial function. Furthermore, all participants will be screened for depression (Geriatric Depression Scale) and psychiatric symptoms (Neuropsychiatric Inventory and Symptom Checklist). The patients will be categorized in accordance with their motor symptoms via cluster analysis for the purpose of analyzing the effect of psychiatric symptoms, depression, and age of disease onset, disease duration, and medication on cognition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2007
CompletedFirst Posted
Study publicly available on registry
May 22, 2007
CompletedStudy Start
First participant enrolled
August 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJanuary 14, 2013
January 1, 2013
4.3 years
May 21, 2007
January 11, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cognitive measures
1 hour
Study Arms (1)
Parkinson's disease
Pt with parkinsons disease
Eligibility Criteria
77 patients with PD and 30 healthy control participants
You may qualify if:
- Idiopathic Parkinson's in accordance to UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria,
- Born and raised in Denmark ,
- \>50 years
You may not qualify if:
- Cerebrovascular disease,
- Dementia not caused by Parkinson's Disease,
- Metabolism anomaly,
- Abuse of drugs, medication or alcohol,
- History of head injuries,
- Severe psychiatric disorder, excluding depression,
- Resident outside the region of Aarhus h) DBS -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus Universitetshospital
Aarhus, 8000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Karen Østergaard, neurologist
Aarhus University Hospital
- STUDY CHAIR
Lars Larsen, MSc, PhD, Associate Professor
The Institute of Psychology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2007
First Posted
May 22, 2007
Study Start
August 1, 2007
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
January 14, 2013
Record last verified: 2013-01